BimAb Bio
We are a pioneering biotech startup offering consultations and services to cater to your growing need for discovering and engineering reagents for research, diagnostics, and therapeutics. Our diverse range of reagents includes monoclonal and bispecific antibodies, nanobodies, and short peptides. With our deep expertise of in vitro discovering and engineering the affinity, specificity, stability, and expression of your selected biologics, our mission is to push the boundaries of science and deliver reliable and risk-free lead molecules that will advance your research in diagnostics and therapeutics.
We are a pioneering biotech startup offering consultations and services to cater to your growing need for discovering and engineering reagents for research, diagnostics, and therapeutics. Our diverse range of reagents includes monoclonal and bispecific antibodies, nanobodies, and short peptides. With our deep expertise of in vitro discovering and engineering the affinity, specificity, stability, and expression of your selected biologics, our mission is to push the boundaries of science and deliver reliable and risk-free lead molecules that will advance your research in diagnostics and therapeutics.
Our Technology
Our Technology
Our proprietary in vitro discovery and engineering platform enables us rapidly screen billions of variants and isolate the ones with the best properties and lowest liability.
Research & Development
Research & Development
Our dedicated R&D team is engaged in developing a wide range of biologics modalities, including monoclonal and bispecific antibodies, nanobodies, and short peptides, all customized to meet your specific requirements.
Partnerships
Partnerships
We enthusiastically invite potential partners to get in touch with us regarding licensing our cutting-edge technologies and platform.